1. Home
  2. SBSW vs BLTE Comparison

SBSW vs BLTE Comparison

Compare SBSW & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$7.98

Market Cap

5.9B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$150.00

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSW
BLTE
Founded
2013
2018
Country
South Africa
United States
Employees
72668
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SBSW
BLTE
Price
$7.98
$150.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$19.93
$198.00
AVG Volume (30 Days)
5.1M
192.7K
Earning Date
02-20-2026
05-08-2026
Dividend Yield
2.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$43.55
N/A
Revenue Next Year
N/A
$492.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$59.12
52 Week High
$21.29
$200.00

Technical Indicators

Market Signals
Indicator
SBSW
BLTE
Relative Strength Index (RSI) 32.79 51.38
Support Level N/A $146.60
Resistance Level $9.16 $151.41
Average True Range (ATR) 0.31 7.06
MACD 0.05 -0.14
Stochastic Oscillator 8.91 49.82

Price Performance

Historical Comparison
SBSW
BLTE

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other. Group operations are divided into two segments, South African Operations and International and recycling operations.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: